Skip to search formSkip to main contentSkip to account menu

peginterferon alfa-2b 0.2 MG Injection [Sylatron]

Known as: Peginterferon alfa-2b 40 ug in 0.1 mL SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SYLATRON], SYLATRON KIT, Sylatron 0.2 MG Injection 
National Institutes of Health

Related topics

Related topics

8 relations
InjectionPolysorbate 80SODIUM PHOSPHATE, DIBASIC, ANHYDROUSSucrose

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Production of a cellular product consisting of monocytes stimulated with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for human use
Monocytes are myeloid cells that reside in the blood and bone marrow and respond to inflammation. At the site of inflammation… 
2018
2018
A Phase 1 trial of autologous monocytes stimulated ex vivo with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for intra-peritoneal administration in recurrent ovarian cancer
Ovarian cancer has no definitive second line therapeutic options, and largely recurs in the peritoneal cavity. Locoregional… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)